Education
About Us
Working with TipRanks
Follow Us
Agilent (A)
NYSE:A
Earnings Data
Report Date
May 26, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
1.41Last Year’s EPS
1.31Same Quarter Last Year
Strong Buy
Based on 13 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and financial picture: solid top-line growth, maintained full‑year guidance, strong product and commercial momentum (notably in pharma/GLP‑1, CAM/advanced materials, Infinity III and Pro iQ), healthy cash generation and clear benefits from the Ignite operating program. Near-term headwinds—tariff-driven gross margin pressure, an isolated weather disruption (~$10M), and pockets of softness in academia/government, cell analysis and certain smaller end markets—were acknowledged but framed as manageable through pricing, supply‑chain actions and Ignite-led savings. Management maintained disciplined capital allocation, reiterated mid‑term growth drivers (replacement cycles, CDMO expansion, reshoring of semiconductor/pharma manufacturing) and emphasized integration/M&A readiness. Overall, positive execution and momentum outweigh the identified challenges.Company Guidance
Revenue and Core Growth
Q1 revenue of $1.8 billion; core (adjusted) revenue growth of 4.4% year-over-year and reported growth of 7.0%; currency contributed a 2.6% tailwind to reported growth.
Profitability and Guidance
Q1 non-GAAP operating margin of 24.6% (in line with expectations); Q1 EPS of $1.36 (up ~4% year-over-year). Full-year core revenue growth guide maintained at 4%–6% and FY26 non-GAAP EPS raised to $5.90–$6.04 (a $0.04 improvement driven by favorable FX).
Cash Flow, Capital Returns and Balance Sheet
Operating cash flow of $268 million in Q1; capital expenditures $93 million; returned capital via $152 million share repurchases and $72 million dividends; net leverage ratio of 0.8x, supporting continued shareholder returns and M&A optionality.
Ignite Operating System Impact
Ignite delivered measurable financial benefits: doubled pricing realization vs. prior baseline, delivered nearly 200 basis points of pricing in the prior quarter, generated substantial procurement savings, simplified organization, launched tariff mitigation program and aided successful BIOVECTRA integration.
Strong Product and Commercial Momentum
Notable product traction: Infinity III HPLC driving high-single-digit LC growth and share gains; Pro iQ single-quad LC/MS family grew >40% in the quarter; Altura columns doubled biocolumn growth to >30%; Omnis expansion and new S-540-MD Slide Scanner launched.
End-Market Strengths
Pharma grew 7% (with GLP-1-related revenue up ~50%); CAM (chemicals & advanced materials) grew 9% with advanced materials >20%; diagnostics & clinical grew 7%. Instrument book-to-bill at or above 1 for the eighth consecutive quarter.
Specialty CDMO Performance
Specialty CDMO grew low double digits in Q1 with the company reiterating expectation of mid-teens growth for the fiscal year; BIOVECTRA integration cited as successful and accretive to execution capability.
Commercial Wins and New Contracts
Enterprise services momentum (accounts with nearly all top-20 biopharma), 18 competitive displacements in 3 years, and a $9 million TSA contract for the Raman Insight BRT system secured in Q1.
A Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
A Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 25, 2026 | $124.72 | $120.97 | -3.01% |
Oct 31, 2025 | $146.10 | $144.43 | -1.14% |
Aug 27, 2025 | $118.24 | $124.49 | +5.28% |
May 28, 2025 | $110.23 | $112.61 | +2.16% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Agilent (A) report earnings?
Agilent (A) is schdueled to report earning on May 26, 2026, After Close (Confirmed).
What is Agilent (A) earnings time?
Agilent (A) earnings time is at May 26, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is A EPS forecast?
A EPS forecast for the fiscal quarter 2026 (Q2) is 1.41.
